Xponance’s Concentrix CNXC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
– Sell
-5,219
Closed -$241K – 1579
2025
Q3
$241K Sell
5,219
-145
-3% -$7.74K ﹤0.01% 1266
2025
Q2
$284K Sell
5,364
-196
-4% -$10.4K ﹤0.01% 1167
2025
Q1
$309K Buy
5,560
+20
+0.4% +$958 ﹤0.01% 1093
2024
Q4
$240K Buy
5,540
+455
+9% +$20.2K ﹤0.01% 1222
2024
Q3
$261K Buy
5,085
+8
+0.2% +$536 ﹤0.01% 1135
2024
Q2
$321K Sell
5,077
-458
-8% -$27.5K ﹤0.01% 1038
2024
Q1
$367K Sell
5,535
-156
-3% -$12.7K ﹤0.01% 1028
2023
Q4
$559K Buy
5,691
+541
+11% +$47.1K 0.01% 895
2023
Q3
$413K Sell
5,150
-53
-1% -$4.16K 0.01% 959
2023
Q2
$420K Sell
5,203
-454
-8% -$42.5K 0.01% 961
2023
Q1
$688K Buy
5,657
+46
+0.8% +$6.25K 0.01% 794
2022
Q4
$747K Buy
5,611
+567
+11% +$68.9K 0.01% 737
2022
Q3
$563K Sell
5,044
-98
-2% -$12.5K 0.01% 795
2022
Q2
$697K Buy
5,142
+440
+9% +$66.2K 0.01% 714
2022
Q1
$783K Sell
4,702
-20
-0.4% -$3.8K 0.01% 694
2021
Q4
$843K Sell
4,722
-140
-3% -$25K 0.01% 679
2021
Q3
$861K Buy
4,862
+15
+0.3% +$2.48K 0.02% 630
2021
Q2
$779K Buy
4,847
+457
+10% +$70.3K 0.01% 706
2021
Q1
$657K Buy
4,390
+75
+2% +$9.09K 0.01% 651
2020
Q4
$426K Buy
+4,315
New +$431K 0.01% 815

Other funds holding CNXC

Xponance's CNXC Position: Q4 2025 in Review

Xponance sold out of Concentrix (CNXC) in Q4 2025, closing a stake of 5,219 shares — an estimated $241K sold.

Xponance first reported a position in CNXC in Q4 2020 and held it in 20 quarters. The position peaked at $861K in Q3 2021. 337 funds tracked by Wall St. Rank hold CNXC as of Q4 2025.

  • Xponance reported no remaining Concentrix position as of Q4 2025 after selling out during the quarter.
  • Xponance sold 5,219 Concentrix shares in Q4 2025, an estimated $241K.
  • Xponance first reported a position in Concentrix in Q4 2020 and held it in 20 quarters.
  • Xponance's Concentrix position peaked at $861K in Q3 2021.
  • 337 funds tracked by Wall St. Rank held Concentrix as of Q4 2025.

Based on Xponance's 13F filing for Q4 2025, filed 12 Feb 2026.